Actively Recruiting
Clinical Study of Stroke Recurrence and Characteristics in Patients With Acute Ischemic Stroke and Active Cancer A Multicenter Prospective Observational Study
Led by Osaka University · Updated on 2026-09-21
500
Participants Needed
1
Research Sites
248 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a multicenter prospective observational study across 24 hospitals in Japan to understand recurrent ischemic stroke in people with active cancer who experience acute ischemic stroke. The study aims to find out how often ischemic stroke recurs within three months, which clinical factors may be linked to recurrence, and what other clinical outcomes occur during follow-up. Participants receive medical care determined by their own doctors and are not assigned to specific treatments by this study. Information about their cancer, stroke details, test results, treatments, and subsequent clinical outcomes, including recurrent ischemic stroke, will be collected during the study period. Participants will be followed up for three months after enrollment to observe for recurrent ischemic stroke and other health events. The primary outcome measured is the percentage of participants who experience a recurrent ischemic stroke within this timeframe. The study will gather clinical data and outcomes without altering standard medical care.
CONDITIONS
Brief Title
Acute Ischemic Stroke in Patients With Active Cancer
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here